Role and Importance of Pulmonary Function test in Pulmonary Involvement of COVID-19: A Review Study
Novelty in Biomedicine,
Vol. 12 No. 3 (2024),
6 July 2024
,
Page 131- 136
https://doi.org/10.22037/nbm.v12i3.44571
Abstract
Background: Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is the greatest pandemic in the world. This virus involves the respiratory system, causes pulmonary dysfunction, and causes coronavirus disease (COVID-19). Pulmonary dysfunction due to COVID-19 may be asymptomatic, mild, moderate, and severe/critical. COVID-19 may involve other organs, and its sequelae may be persistent for a long time. The pulmonary function test is a method for evaluating the lungs in people. In this study, we reviewed the results of pulmonary function test (PFT) in patients with a history of COVID-19 involvement based on previous studies.
Materials and Methods: The present review was conducted in 2024 using the keywords COVID-19, pulmonary function test, recovery, and pulmonary involvement in English. Eligible articles (articles containing the mentioned keywords) published during the years 2019 to 2023 were searched in Scopus, Pubmed, Wiley, and Google Scholar international databases. Relevant articles were identified, and after review, the most important and valuable points were presented.
Results: PTF should not be done during COVID-19 involvement because it increases the rate of disease transmission. Small airway dysfunction, restrictive ventilatory dysfunction, and pulmonary diffusion impairment patterns are the most common findings in the PFTs of patients with a history of COVID-19. PFT improves gradually after the recovery of pulmonary involvement of COVID-19 for two years, even in patients with severe or critical forms of COVID-19.
Conclusion: In this review, we summarized the results of studies about pulmonary function tests after COVID-19 involvement in survivors. Small airway dysfunction, restrictive ventilatory dysfunction, and pulmonary diffusion impairment are the most common findings in the PFT of survivors of COVID-19. These patterns are more prevalent among patients with severe or critical forms of COVID-19, and they are associated with the risk factors of COVID-19 severity, such as age, underlying disease, and pulmonary disorders. Forced vital capacity and diffusion capacity of lungs for carbon monoxide decreased in patients with COVID-19, and forced expiratory volume in 1 second (FEV1)/FVC and residual volume (RV) increased in these patients and they were associated with COVID-19 severity. The pulmonary involvement of COVID-19 recovers over time, and after two years, patients return to their baseline PFTs.
- 18 F FDG PET/CT
How to Cite
References
The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nature microbiology. 2020;5(4):536-44.
Gorbalenya AE, Baker SC, Baric RS, et al. Coronaviridae Study Group of the International Committee on Taxonomy of Viruses. The species severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nat. Microbiol. 2020;5(4):536-44.
Kim I-H, Kang B-H, Seo SH, et al. Early laboratory preparedness of the Korea Disease Control and Prevention Agency and response to unknown pneumonia outbreak from Wuhan, China, in January 2020. Annals of Laboratory Medicine. 2021;41(6):532-9.
Bai Y, Yao L, Wei T, et al. Presumed asymptomatic carrier transmission of COVID-19. Jama. 2020;323(14):1406-7.
Van Doremalen N, Bushmaker T, Morris DH, et al. Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1. New England journal of medicine. 2020;382(16):1564-7.
Zhu N, Zhang D, Wang W, et al. A novel coronavirus from patients with pneumonia in China, 2019. New England journal of medicine. 2020;382(8):727-33.
Li Y, Zhou W, Yang L, You R. Physiological and pathological regulation of ACE2, the SARS-CoV-2 receptor. Pharmacological research. 2020;157:104833.
Hoffmann M, Kleine-Weber H, Schroeder S, et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. cell. 2020;181(2):271-80.
Guan W-j, Ni Z-y, Hu Y, et al. Clinical characteristics of coronavirus disease 2019 in China. New England journal of medicine. 2020;382(18):1708-20.
Xu X, Chen P, Wang J, et al. Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission. Science China Life Sciences. 2020;63:457-60.
Nicastri E, D’Abramo A, Lepore L, et al. The evolution of clinical and scientific evidence-based management guidelines for Covid-19 disease: A longitudinal descriptive analysis. Available at SSRN 3672327. 2020.
Pau A, Aberg J, Baker J, et al. National Institutes of Health COVID-19 Treatment Guidelines Panel. Convalescent plasma for the treatment of COVID-19: perspectives of the National Institutes of Health COVID-19 Treatment Guidelines Panel. Ann Intern Med. 2021;174(1):93-5.
Health NIo. National Institutes of Health COVID-19 treatment guidelines. Therapeutic Management of Nonhospitalized Adults With COVID. 2021;19.
Lu R, Zhao X, Li J, et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. The lancet. 2020;395(10224):565-574.
Hull JH, Lloyd JK, Cooper BG. Lung function testing in the COVID-19 endemic. The Lancet Respiratory Medicine. 2020;8(7):666-7.
Ponce M, Sankari A, Sharma S. Pulmonary Function Tests. 2022 Sep 3. StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing. 2023.
Contini M, Conte E, Agostoni P. Lung function evaluation in heart failure: possible pitfalls. Breathe. 2020;16(1).
Borg BM, Osadnik C, Adam K, et al. Pulmonary function testing during SARS‐CoV‐2: An ANZSRS/TSANZ position statement. Respirology. 2022;27(9):688-719.
Wainstein EJ, Peroni HJ, Ferreyro BL, et al. Incidence of COVID-19 after pulmonary function tests: a retrospective cohort study. Revista de la Facultad de Ciencias Médicas. 2021;78(4):367.
Mo X, Jian W, Su Z, et al. Abnormal pulmonary function in COVID-19 patients at time of hospital discharge. European Respiratory Journal. 2020;55(6).
Lv D, Chen X, Mao L, et al. Pulmonary function of patients with 2019 novel coronavirus induced pneumonia: a retrospective cohort study. 2020.
Polese J, Sant’Ana L, Moulaz IR, et al. Pulmonary function evaluation after hospital discharge of patients with severe COVID-19. Clinics. 2021;76.
Wu Q, Zhong L, Li H, et al. A follow-up study of lung function and chest computed tomography at 6 months after discharge in patients with coronavirus disease 2019. Canadian Respiratory Journal. 2021;2021:1-7.
van Willigen HD, Wynberg E, Verveen A, et al. One-fourth of COVID-19 patients have an impaired pulmonary function after 12 months of disease onset. Plos one. 2023;18(9):e0290893.
Suppini N, Fira-Mladinescu O, Traila D, et al. Longitudinal Analysis of Pulmonary Function Impairment One Year Post-COVID-19: A Single-Center Study. Journal of Personalized Medicine. 2023;13(8):1190.
Toh MR, Teo YR, Poh LCR, et al. Impact of COVID infection on lung function test and quality of life. Scientific Reports. 2023;13(1):17275.
Ware Jr JE, Gandek B. Overview of the SF-36 health survey and the international quality of life assessment (IQOLA) project. Journal of clinical epidemiology. 1998;51(11):903-12.
Lewis KL, Helgeson SA, Tatari MM, Mallea JM, Baig HZ, Patel NM. COVID-19 and the effects on pulmonary function following infection: A retrospective analysis. EClinicalMedicine. 2021;39.
Zhang H, Li X, Huang L, et al. Lung-function trajectories in COVID-19 survivors after discharge: A two-year longitudinal cohort study. EClinicalMedicine. 2022;54.
Huang L, Li X, Gu X, et al. Health outcomes in people 2 years after surviving hospitalisation with COVID-19: a longitudinal cohort study. The Lancet Respiratory Medicine. 2022;10(9):863-76.
Li D, Liao X, Liu Z, et al. Healthy outcomes of patients with COVID-19 two years after the infection: a prospective cohort study. Emerging Microbes & Infections. 2022;11(1):2680-8.
Togami E, Griffith B, Mahran M, et al. The World Health Organization’s public health intelligence activities during the COVID-19 pandemic response, December 2019 to December 2021. Eurosurveillance. 2022;27(49):2200142.
Čivljak R, Markotić A, Kuzman I. The third coronavirus epidemic in the third millennium: what’s next? Croatian medical journal. 2020;61(6):1-4.
Catanzaro M, Fagiani F, Racchi M, Corsini E, Govoni S, Lanni C. Immune response in COVID-19: addressing a pharmacological challenge by targeting pathways triggered by SARS-CoV-2. Signal transduction and targeted therapy. 2020;5(1):84.
Jacobs M, Van Eeckhoutte HP, Wijnant SR, et al. Increased expression of ACE2, the SARS-CoV-2 entry receptor, in alveolar and bronchial epithelium of smokers and COPD subjects. European Respiratory Journal. 2020;56(2).
Zhou P, Yang X-L, Wang X-G, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. nature. 2020;579(7798):270-3.
Raut ER, Raut AR. A Review on Coronavirus Disease-A Future Challenge for Mankind (Focusing on Indian Situation). Coronaviruses. 2021;2(8):9-13.
Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. The lancet. 2020;395(10229):1054-62.
Brasil. Ministério da Saúde. Secretaria de Vigilância em Saúde. Boletim Epidemiológico: Ministério da Saúde Brasília; 2020.
Lighter J, Phillips M, Hochman S, et al. Obesity in patients younger than 60 years is a risk factor for Covid-19 hospital admission. Clinical Infectious Diseases. 2020;71(15):896-7.
Rusu I, Turlacu M, Micheu MM. Acute myocardial injury in patients with COVID-19: Possible mechanisms and clinical implications. World Journal of Clinical Cases. 2022;10(3):762.
Scappaticcio L, Pitoia F, Esposito K, Piccardo A, Trimboli P. Impact of COVID-19 on the thyroid gland: an update. Reviews in endocrine and metabolic disorders. 2020:1-13.
Davis HE, McCorkell L, Vogel JM, Topol EJ. Long COVID: major findings, mechanisms and recommendations. Nature Reviews Microbiology. 2023;21(3):133-46.
Franczuk M, Przybyłowski T, Czajkowska-Malinowska M, et al. Spirometry during the SARS-CoV-2 pandemic. Guidelines and practical advice from the expert panel of Respiratory Physiopathology Assembly of Polish Respiratory Society. Advances in Respiratory Medicine. 2020;88(6):640-50.
Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The lancet. 2020;395(10223):497-506.
- Abstract Viewed: 202 times
- pdf Downloaded: 145 times